scispace - formally typeset
D

Diane J. Ordway

Researcher at Colorado State University

Publications -  120
Citations -  6268

Diane J. Ordway is an academic researcher from Colorado State University. The author has contributed to research in topics: Mycobacterium tuberculosis & Tuberculosis. The author has an hindex of 42, co-authored 112 publications receiving 5456 citations. Previous affiliations of Diane J. Ordway include Universidade Nova de Lisboa & University of Lisbon.

Papers
More filters
Journal ArticleDOI

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Josephine M. Bryant, +90 more
- 11 Nov 2016 - 
TL;DR: Using whole-genome analysis of a global collection of clinical isolates, it is shown that the majority of M. abscessus infections are acquired through transmission, potentially via fomites and aerosols, of recently emerged dominant circulating clones that have spread globally.

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

TL;DR: In this paper, the authors used whole-genome analysis of a global collection of clinical isolates to show that the majority of M. abscessus infections are acquired through transmission, potentially via fomites and aerosols, of recently emerged dominant circulating clones.
Journal ArticleDOI

Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection

TL;DR: It is found that in primary human macrophages, concentrations of azithromycin achieved during therapeutic dosing blocked autophagosome clearance by preventing lysosomal acidification, thereby impairing autophagic and phagosomal degradation and resulted in chronic infection with NTM in mice.
Journal ArticleDOI

A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug Resistant Mycobacterium tuberculosis

TL;DR: Data is presented that suggest that a vaccine based on immunization with an oil-in-water adjuvant and a recombinant four-protein fusion protein may be appropriately tested in a human clinical trial and the approach presented in this paper is a promising one.
Journal ArticleDOI

The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation

TL;DR: It is demonstrated that although type I IFN does play an inhibitory role, this response was most apparent during the chronic disease stage and was common to all M. tuberculosis strains tested.